IDH2 and chondrosarcoma: Despite their significant role in the early stages of tumor development, the prognostic value of IDH mutations in chondrosarcoma appears to be controversial, with different studies indicating a better [41] or worse [24] prognosis, or no association between IDH mutation and outcome [42].